Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer.

Chemotherapy Cystatin C Nephrotoxicity Pediatrics

Journal

Cancer chemotherapy and pharmacology
ISSN: 1432-0843
Titre abrégé: Cancer Chemother Pharmacol
Pays: Germany
ID NLM: 7806519

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 07 07 2023
accepted: 14 09 2023
pubmed: 4 10 2023
medline: 4 10 2023
entrez: 3 10 2023
Statut: ppublish

Résumé

We recently proposed an equation to estimate the glomerular filtration rate (GFR) in children with cancer based on plasma cystatin C and serum creatinine levels together with body weight (the "CysPed equation"). The current clinical study reports a prospective evaluation of this equation in 18 children treated by nephrotoxic chemotherapy. The CysPed equation resulted in less bias and greater precision compared to two equations previously proposed equations by Schwartz, with or without plasma cystatin C. Moreover, the decrease in GFR due to chemotherapy was clearly identified by the CysPed equation. This equation may be used to monitor the renal function in childhood cancer units.

Identifiants

pubmed: 37789166
doi: 10.1007/s00280-023-04597-6
pii: 10.1007/s00280-023-04597-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-395

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Lambert M, White-Koning M, Alonso M et al (2021) Plasma cystatin C is a marker of renal glomerular injury in children treated with cisplatin or ifosfamide. Pediatr Blood Cancer 68(1):e28747. https://doi.org/10.1002/pbc.28747
doi: 10.1002/pbc.28747 pubmed: 33058496
Schwartz GJ, Schneider MF, Maier PS et al (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82(4):445–453. https://doi.org/10.1038/ki.2012.169
doi: 10.1038/ki.2012.169 pubmed: 22622496 pmcid: 3433576
Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34(3):571–590. https://doi.org/10.1016/s0031-3955(16)36251-4
doi: 10.1016/s0031-3955(16)36251-4 pubmed: 3588043
Spencer S, Desborough R, Bhandari S (2023) Should cystatin C eGFR become routine clinical practice? Biomolecules 13(7):1075. https://doi.org/10.3390/biom13071075
doi: 10.3390/biom13071075 pubmed: 37509111 pmcid: 10377068
Bouvet Y, Bouissou F, Coulais Y et al (2006) GFR is better estimated by considering both serum cystatin C and creatinine levels. Pediatr Nephrol Berl Ger 21(9):1299–1306. https://doi.org/10.1007/s00467-006-0145-z
doi: 10.1007/s00467-006-0145-z
Inker LA, Schmid CH, Tighiouart H et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20–29. https://doi.org/10.1056/NEJMoa1114248
doi: 10.1056/NEJMoa1114248 pubmed: 22762315 pmcid: 4398023
Björk J, Grubb A, Larsson A et al (2015) Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden. Clin Chem Lab Med 53(3):403–414. https://doi.org/10.1515/cclm-2014-0578
doi: 10.1515/cclm-2014-0578 pubmed: 25274955
Simonsen JA, Thilsing-Hansen K, Høilund-Carlsen PF, Gerke O, Andersen TL (2020) Glomerular filtration rate: comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA revisited. Scand J Clin Lab Invest 80(5):408–411. https://doi.org/10.1080/00365513.2020.1759138
doi: 10.1080/00365513.2020.1759138 pubmed: 32362172
Vidal-Petiot E, Courbebaisse M, Livrozet M et al (2021) Comparison of 51Cr-EDTA and 99mTc-DTPA for glomerular filtration rate measurement. J Nephrol 34(3):729–737. https://doi.org/10.1007/s40620-020-00932-9
doi: 10.1007/s40620-020-00932-9 pubmed: 33661505
Chantler C, Garnett ES, Parsons V, Veall N (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37(1):169–180
pubmed: 4980763
McMeekin H, Barnfield M, Wickham F, Burniston M (2019) 99mTc DTPA vs. 51Cr EDTA for glomerular filtration rate measurement: is there a systematic difference? Nucl Med Commun 40(12):1224. https://doi.org/10.1097/MNM.0000000000001101
doi: 10.1097/MNM.0000000000001101 pubmed: 31633648
Andersen TB, Jødal L, Nielsen NS, Petersen LJ (2019) Comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA: can one tracer replace the other? Scand J Clin Lab Invest 79(7):463–467. https://doi.org/10.1080/00365513.2019.1658217
doi: 10.1080/00365513.2019.1658217 pubmed: 31502901

Auteurs

Marie Lambert (M)

CRCT, Université de Toulouse, Inserm, Toulouse, France.
Oncopole Claudius-Regaud, IUCT-Oncopole, 1, Avenue Irène Joliot-Curie, 31059, Toulouse Cedex, France.

Mathieu Alonso (M)

Unité de Radiopharmacie, CHU de Toulouse-Purpan, Toulouse, France.

Caroline Munzer (C)

Unité de Recherche Clinique Pédiatrique, Hôpital des Enfants, CHU Toulouse, Toulouse, France.
Unité d'Hémato-Oncologie, Hôpital des Enfants, CHU Toulouse, Toulouse, France.

Marie-Christine Zimoch (MC)

Oncopole Claudius-Regaud, IUCT-Oncopole, 1, Avenue Irène Joliot-Curie, 31059, Toulouse Cedex, France.

Laurence Malard (L)

Oncopole Claudius-Regaud, IUCT-Oncopole, 1, Avenue Irène Joliot-Curie, 31059, Toulouse Cedex, France.

Marion Gambart (M)

Unité d'Hémato-Oncologie, Hôpital des Enfants, CHU Toulouse, Toulouse, France.

Marie-Pierre Castex (MP)

Unité d'Hémato-Oncologie, Hôpital des Enfants, CHU Toulouse, Toulouse, France.

Carla Martins (C)

Unité de Recherche Clinique Pédiatrique, Hôpital des Enfants, CHU Toulouse, Toulouse, France.

Marlène Pasquet (M)

Unité d'Hémato-Oncologie, Hôpital des Enfants, CHU Toulouse, Toulouse, France.
CRCT, Equipe 16, IUCT-Oncopole, Toulouse, France.

Etienne Chatelut (E)

CRCT, Université de Toulouse, Inserm, Toulouse, France. Chatelut.etienne@iuct-oncopole.fr.
Oncopole Claudius-Regaud, IUCT-Oncopole, 1, Avenue Irène Joliot-Curie, 31059, Toulouse Cedex, France. Chatelut.etienne@iuct-oncopole.fr.

Classifications MeSH